Literature DB >> 7569793

Estrogen receptors in the human male bladder, prostatic urethra, and prostate. An immunohistochemical and biochemical study.

A Bødker1, E Balslev, B R Juul, H Stimpel, H H Meyhoff, H Hedlund, P Hedlund, H G Iversen, K E Andersson.   

Abstract

The distribution and quantity of estrogen receptors (ERs) in the human male bladder, prostatic urethra and the prostate were studied in eight males with recurrent papillomas of the bladder or monosymptomatic hematuria (median age 61 years), 14 men undergoing transurethral resection due to benign prostatic hyperplasia (median age 70 years), and nine men undergoing cystectomy due to malignant tumour of the bladder (median age 70 years). In the first group of patients, biopsies for immunohistochemical examination were obtained from the bladder vault, bottom, both side-walls, the trigone area, and the mid-portion of the prostatic urethra, and in the second group from three locations of the prostatic urethra (bladder neck, mid-portion and veramontanum). In the third group, tissue specimens were taken from the vault of the bladder, prostatic urethra, and the prostate, for immunohistochemical as well as biochemical analysis. In the first group, ERs were found in three out of eight specimens of the prostatic urethra, and in one of these, ERs were confined to periurethral glands. ERs could not be demonstrated in any of the bladder-biopsies. In the second group, ERs were not found in the bladder neck, but were seen in four preparations from the veramontanum and in two from the midportion of the urethra. ERs were located in the urothelium and periurethral glands. In the third group, ERs were seen immunohistochemically in the prostatic urethra (two cases) and the prostatic stromal tissue (two cases). ERs could be demonstrated in the bladder neither by immunohistochemistry nor biochemically.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7569793     DOI: 10.3109/00365599509180557

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  6 in total

1.  Molecular mechanisms of bladder outlet obstruction in transgenic male mice overexpressing aromatase (Cyp19a1).

Authors:  Wei Lin; Nafis A Rahman; Jian Lin; Hua Zhang; Kemian Gou; Wanpeng Yu; Dahai Zhu; Ning Li; Ilpo Huhtaniemi; Xiangdong Li
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

2.  Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen.

Authors:  Suraj Konnath George; Veronica Tovar-Sepulveda; Steven S Shen; Weiguo Jian; Yiqun Zhang; Susan G Hilsenbeck; Seth P Lerner; Carolyn L Smith
Journal:  Transl Oncol       Date:  2013-06-01       Impact factor: 4.243

3.  Urothelial mucosal signaling and the overactive bladder-ICI-RS 2013.

Authors:  Lori A Birder; Karl-Erik Andersson; Anthony J Kanai; Ann T Hanna-Mitchell; Chris H Fry
Journal:  Neurourol Urodyn       Date:  2014-05-16       Impact factor: 2.696

4.  Identification of telocytes in the upper lamina propria of the human urinary tract.

Authors:  Thomas Gevaert; Rita De Vos; Frank Van Der Aa; Steven Joniau; Joost van den Oord; Tania Roskams; Dirk De Ridder
Journal:  J Cell Mol Med       Date:  2012-09       Impact factor: 5.310

5.  Prognostic value of sex-hormone receptor expression in non-muscle-invasive bladder cancer.

Authors:  Jong Kil Nam; Sung Woo Park; Sang Don Lee; Moon Kee Chung
Journal:  Yonsei Med J       Date:  2014-09       Impact factor: 2.759

Review 6.  Sex differences in lower urinary tract biology and physiology.

Authors:  Benjamin Abelson; Daniel Sun; Lauren Que; Rebecca A Nebel; Dylan Baker; Patrick Popiel; Cindy L Amundsen; Toby Chai; Clare Close; Michael DiSanto; Matthew O Fraser; Stephanie J Kielb; George Kuchel; Elizabeth R Mueller; Mary H Palmer; Candace Parker-Autry; Alan J Wolfe; Margot S Damaser
Journal:  Biol Sex Differ       Date:  2018-10-22       Impact factor: 5.027

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.